Dr Reddys Laboratories RDY
NYSE RDY
$13.28 +0.20 (+1.53%)
As of: Oct 20, 2026 · 12:01 PM EDT

Dr Reddys Laboratories (RDY) Receivables (2009 - 2026)

Updated

Dr Reddys Laboratories (RDY) posted Receivables of $1.06 billion for the quarter ended Jun 30, 2026, down 4.5% from $1.11 billion a year earlier and down 4.1% from the prior quarter.

Analysis

Dr Reddys Laboratories (RDY) Receivables (2009 - 2026) Analysis & Trends

As of Mar 31, 2026, Dr Reddys Laboratories' Receivables came in at $1.08 billion, up 2.0% from the prior year.

  • Annual Receivables shows a five-year compound annual growth rate of -4.3% (years ended Mar 2021 to Mar 2026).
  • In prior years, Dr Reddys Laboratories' Receivables was $1.06 billion in the year ended Mar 31, 2025 (+9.9%), $963 million in the year ended Mar 31, 2024 (-32.1%), $1.42 billion in the year ended Mar 31, 2023 (-8.2%) and $1.54 billion in the year ended Mar 31, 2022 (+14.6%).
  • The figure for the quarter ended Jun 30, 2026 stands as the lowest quarterly Receivables since the quarter ended Mar 31, 2025.
  • On a year-over-year basis, Receivables increased in seven of the last eight quarters, with growth averaging 9.6%.
  • The strongest year-over-year quarter for Receivables in the past five years was the quarter ended Sep 30, 2021, with growth of 36.1%; the weakest was the quarter ended Sep 30, 2023, with a decline of 51.1%.
  • According to Business Quant data, Receivables for the three prior quarters was $1.11 billion (quarter ended Mar 31, 2026), $1.16 billion (quarter ended Dec 31, 2025) and $1.12 billion (quarter ended Sep 30, 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Receivables (Qtr)
1 Eli Lilly 1,160.09 Bn 1,128.68 Bn 19.71 Bn 23.48 Bn
2 Johnson & Johnson 624.76 Bn 543.28 Bn 17.26 Bn 19.05 Bn
3 AbbVie 511.79 Bn 484.90 Bn 12.70 Bn 13.82 Bn
4 Merck 366.25 Bn 320.63 Bn 12.21 Bn 12.56 Bn
5 Novartis Ag 297.28 Bn 261.27 Bn 11.24 Bn 9.64 Bn
6 Astrazeneca 261.26 Bn 234.95 Bn 12.86 Bn 15.68 Bn
7 Amgen 234.84 Bn 190.23 Bn 7.24 Bn 10.23 Bn
8 Gilead Sciences 193.93 Bn 168.13 Bn 6.22 Bn 5.06 Bn
9 Pfizer 171.68 Bn 118.33 Bn 10.94 Bn 12.49 Bn
10 Dr Reddys Laboratories 11.07 Bn 10.44 Bn 396.53 Mn 1.06 Bn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 1.06 Bn
Mar 31, 2026 1.07 Bn
Dec 31, 2025 1.15 Bn
Sep 30, 2025 1.10 Bn
Jun 30, 2025 1.11 Bn
Mar 31, 2025 1.06 Bn
Dec 31, 2024 1.07 Bn
Sep 30, 2024 1.01 Bn
Jun 30, 2024 971.69 Mn
Mar 31, 2024 962.89 Mn
Dec 31, 2023 952.80 Mn
Sep 30, 2023 838.08 Mn
Jun 30, 2023 939.32 Mn
Mar 31, 2023 882.88 Mn
Dec 31, 2022 905.97 Mn
Sep 30, 2022 944.85 Mn
Jun 30, 2022 928.71 Mn
Mar 31, 2022 880.47 Mn
Dec 31, 2021 839.80 Mn
Sep 30, 2021 923.90 Mn
API Access

Dr Reddys Laboratories Receivables API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=receivables&ticker=RDY&period=max&api_key=YOUR_API_KEY